Journal Mobile Options
Table of Contents
Vol. 219, No. 4, 2009
Issue release date: November 2009
Section title: Letter to Dermatology
Free Access
Dermatology 2009;219:357–358
(DOI:10.1159/000243805)

Bullous Pemphigoid during Long-Term TNF-α Blocker Therapy

Bordignon M.a · Belloni-Fortina A.a · Pigozzi B.b · Tarantello M.a · Alaibac M.a
aUnit of Dermatology, University of Padua, and bVeneto Institute of Oncology, IRCCS, Padua, Italy
email Corresponding Author


  

Key Words

  • Adverse drug reaction
  • Bullous pemphigoid
  • Etanercept
  • Tumor necrosis factor

  

Author Contacts

Mauro Alaibac, MD, PhD
Via Cesare Battisti 206
IT–35128 Padova (Italy)
Tel. +39 049 821 2901, Fax +39 049 821 8891
E-Mail mauro.alaibac@unipd.it

  

Article Information

Published online: October 1, 2009
Number of Print Pages : 2

  

Publication Details

Dermatology

Vol. 219, No. 4, Year 2009 (Cover Date: November 2009)

Journal Editor: Saurat J.-H. (Geneva)
ISSN: 1018-8665 (Print), eISSN: 1421-9832 (Online)

For additional information: http://www.karger.com/DRM


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

First-Page Preview
Abstract of Letter to Dermatology

  

Author Contacts

Mauro Alaibac, MD, PhD
Via Cesare Battisti 206
IT–35128 Padova (Italy)
Tel. +39 049 821 2901, Fax +39 049 821 8891
E-Mail mauro.alaibac@unipd.it

  

Article Information

Published online: October 1, 2009
Number of Print Pages : 2

  

Publication Details

Dermatology

Vol. 219, No. 4, Year 2009 (Cover Date: November 2009)

Journal Editor: Saurat J.-H. (Geneva)
ISSN: 1018-8665 (Print), eISSN: 1421-9832 (Online)

For additional information: http://www.karger.com/DRM


Article / Publication Details

Published online: 10/1/2009
Issue release date: November 2009

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0

ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)

For additional information: http://www.karger.com/DRM


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.